Get alerts when ZEAL.CO reports next quarter
Set up alerts — freeShares fell 1.3% after the update, a relatively flat reaction. The transcript highlighted pipeline and partnership progress, including positive petrelintide data, but did not provide financial results or updated guidance to assess against expectations.
See ZEAL.CO alongside your other holdings
Add to your portfolio — freeTrack Zealand Pharma A/S in your portfolio with real-time analytics, dividend tracking, and more.
View ZEAL.CO Analysis